With the frothiness of the artificial intelligence (AI) craze in full swing, Schrödinger (NASDAQ: SDGR) is a biotech that investors should know about now. While many questions remain about the viability of its business model and its ability to grow in the long term in the face of mounting competition, for the moment it's one of the leaders in the field of information technology-driven drug development. Schrödinger is a leader in the field of technology-assisted drug discovery and development.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles